These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34482535)

  • 21. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19.
    Venter C; Bezuidenhout JA; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
    Bikdeli B; Madhavan MV; Gupta A; Jimenez D; Burton JR; Der Nigoghossian C; Chuich T; Nouri SN; Dreyfus I; Driggin E; Sethi S; Sehgal K; Chatterjee S; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Bertoletti L; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Tafur AJ; Francese DP; Batra J; Falanga A; Clerkin KJ; Uriel N; Kirtane A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Leon MB; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
    Thromb Haemost; 2020 Jul; 120(7):1004-1024. PubMed ID: 32473596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection.
    Magnani HN
    Clin Appl Thromb Hemost; 2021; 27():1076029620977702. PubMed ID: 33539214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence.
    Godino C; Scotti A; Maugeri N; Mancini N; Fominskiy E; Margonato A; Landoni G
    Int J Cardiol; 2021 Feb; 324():261-266. PubMed ID: 33002521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series.
    Lax SF; Skok K; Zechner P; Kessler HH; Kaufmann N; Koelblinger C; Vander K; Bargfrieder U; Trauner M
    Ann Intern Med; 2020 Sep; 173(5):350-361. PubMed ID: 32422076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
    Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
    Rodriguez JJ; Munoz OC; Porres-Aguilar M; Mukherjee D
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(1):23-29. PubMed ID: 33719953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silent hypoxia: higher NO in red blood cells of COVID-19 patients.
    Mortaz E; Malkmohammad M; Jamaati H; Naghan PA; Hashemian SM; Tabarsi P; Varahram M; Zaheri H; Chousein EGU; Folkerts G; Adcock IM
    BMC Pulm Med; 2020 Oct; 20(1):269. PubMed ID: 33066765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
    Bikdeli B; Madhavan MV; Jimenez D; Chuich T; Dreyfus I; Driggin E; Nigoghossian C; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Caprini JA; Tafur AJ; Burton JR; Francese DP; Wang EY; Falanga A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Steg PG; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
    J Am Coll Cardiol; 2020 Jun; 75(23):2950-2973. PubMed ID: 32311448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury.
    Xiang M; Wu X; Jing H; Novakovic VA; Shi J
    Front Cardiovasc Med; 2023; 10():1062491. PubMed ID: 36824451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
    DiNicolantonio JJ; Barroso-Aranda J
    Med Hypotheses; 2020 Oct; 143():110051. PubMed ID: 32650197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.
    Reinhold A; Tzankov A; Matter MS; Mihic-Probst D; Scholl HPN; Meyer P
    Ophthalmic Res; 2021; 64(5):785-792. PubMed ID: 33472206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
    Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
    Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular underpinning of COVID-19.
    Wazny V; Siau A; Wu KX; Cheung C
    Open Biol; 2020 Aug; 10(8):200208. PubMed ID: 32847471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.